JP2024105238A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024105238A5 JP2024105238A5 JP2024060499A JP2024060499A JP2024105238A5 JP 2024105238 A5 JP2024105238 A5 JP 2024105238A5 JP 2024060499 A JP2024060499 A JP 2024060499A JP 2024060499 A JP2024060499 A JP 2024060499A JP 2024105238 A5 JP2024105238 A5 JP 2024105238A5
- Authority
- JP
- Japan
- Prior art keywords
- dengue
- vaccine composition
- dose
- dengue vaccine
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025177428A JP2026031938A (ja) | 2018-09-05 | 2025-10-21 | デング熱ワクチン単位用量及びその投与 |
Applications Claiming Priority (24)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18192793.0 | 2018-09-05 | ||
| EP18192701.3 | 2018-09-05 | ||
| EP18192814 | 2018-09-05 | ||
| EP18192776.5 | 2018-09-05 | ||
| EP18192800 | 2018-09-05 | ||
| EP18192717 | 2018-09-05 | ||
| EP18192800.3 | 2018-09-05 | ||
| EP18192717.9 | 2018-09-05 | ||
| EP18192711.2 | 2018-09-05 | ||
| EP18192787 | 2018-09-05 | ||
| EP18192711 | 2018-09-05 | ||
| EP18192701 | 2018-09-05 | ||
| EP18192787.2 | 2018-09-05 | ||
| EP18192814.4 | 2018-09-05 | ||
| EP18192776 | 2018-09-05 | ||
| EP18192793 | 2018-09-05 | ||
| EP19154334.7 | 2019-01-29 | ||
| EP19154334 | 2019-01-29 | ||
| US16/295,611 | 2019-03-07 | ||
| US16/295,611 US11464815B2 (en) | 2018-09-05 | 2019-03-07 | Dengue vaccine unit dose and administration thereof |
| EP19161184.7 | 2019-03-07 | ||
| EP19161184 | 2019-03-07 | ||
| JP2021512482A JP7579780B2 (ja) | 2018-09-05 | 2019-09-05 | デング熱ワクチン単位用量及びその投与 |
| PCT/US2019/049749 WO2020051334A1 (en) | 2018-09-05 | 2019-09-05 | Dengue vaccine unit dose and administration thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021512482A Division JP7579780B2 (ja) | 2018-09-05 | 2019-09-05 | デング熱ワクチン単位用量及びその投与 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025177428A Division JP2026031938A (ja) | 2018-09-05 | 2025-10-21 | デング熱ワクチン単位用量及びその投与 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024105238A JP2024105238A (ja) | 2024-08-06 |
| JP2024105238A5 true JP2024105238A5 (https=) | 2025-01-14 |
| JP7791925B2 JP7791925B2 (ja) | 2025-12-24 |
Family
ID=69722836
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021512482A Active JP7579780B2 (ja) | 2018-09-05 | 2019-09-05 | デング熱ワクチン単位用量及びその投与 |
| JP2024060499A Active JP7791925B2 (ja) | 2018-09-05 | 2024-04-03 | デング熱ワクチン単位用量及びその投与 |
| JP2025177428A Pending JP2026031938A (ja) | 2018-09-05 | 2025-10-21 | デング熱ワクチン単位用量及びその投与 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021512482A Active JP7579780B2 (ja) | 2018-09-05 | 2019-09-05 | デング熱ワクチン単位用量及びその投与 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025177428A Pending JP2026031938A (ja) | 2018-09-05 | 2025-10-21 | デング熱ワクチン単位用量及びその投与 |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US11590221B2 (https=) |
| EP (3) | EP3846849A1 (https=) |
| JP (3) | JP7579780B2 (https=) |
| KR (1) | KR20210071979A (https=) |
| CN (1) | CN112912106A (https=) |
| AU (4) | AU2019335006B2 (https=) |
| BR (1) | BR112021003962A2 (https=) |
| CA (1) | CA3111332A1 (https=) |
| CO (1) | CO2021003931A2 (https=) |
| DK (1) | DK3620174T3 (https=) |
| EC (1) | ECSP21023398A (https=) |
| ES (1) | ES2908304T3 (https=) |
| IL (2) | IL298307A (https=) |
| MX (1) | MX2021002586A (https=) |
| PE (1) | PE20211545A1 (https=) |
| PH (1) | PH12021550479A1 (https=) |
| SG (1) | SG11202102104SA (https=) |
| WO (1) | WO2020051334A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20231581T1 (hr) | 2013-03-15 | 2024-03-15 | Takeda Vaccines, Inc. | Pripravci i postupci za kimerne konstrukte virusa denga groznice u cjepivima |
| US11007261B2 (en) * | 2016-04-13 | 2021-05-18 | Takeda Vaccines, Inc. | Compositions and methods of vaccination against dengue virus in children and young adults |
| WO2020051334A1 (en) * | 2018-09-05 | 2020-03-12 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
| EP4110381A1 (en) * | 2020-02-27 | 2023-01-04 | Takeda Vaccines, Inc. | Method for removing host cell dna from virus preparation |
| WO2022158097A1 (ja) * | 2021-01-19 | 2022-07-28 | 新田ゼラチン株式会社 | ウイルス安定化剤、ウイルス安定化剤用ゼラチン加水分解物およびウイルス含有組成物 |
| CN112813089A (zh) * | 2021-03-22 | 2021-05-18 | 苏州诺威百奥生物科技有限公司 | 黄病毒科检测用多位点重组抗原的制备方法 |
| CN113913551B (zh) * | 2021-06-22 | 2022-05-13 | 中国检验检疫科学研究院 | 一种登革病毒分型的测序引物、检测方法及试剂盒 |
| AU2023365824A1 (en) | 2022-10-18 | 2025-06-05 | Takeda Vaccines, Inc. | Dengue vaccine formulation |
| EP4357464A1 (en) * | 2022-10-20 | 2024-04-24 | Takeda Vaccines, Inc. | A method for detecting the presence of a dengue virus serotype in a sample containing at least one dengue virus serotype |
| EP4375381B1 (en) * | 2022-11-18 | 2026-02-25 | Takeda Vaccines, Inc. | A method for determining the proportion of a live, attenuated dengue virus having a nucleotide sequence comprising at least one attenuation locus in a formulation |
| CN120271718A (zh) * | 2024-01-05 | 2025-07-08 | 北京昌平实验室 | 针对寨卡/登革病毒的重组抗原、其疫苗组合物及其应用 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4810092A (en) | 1986-02-21 | 1989-03-07 | Midac Corporation | Economical spectrometer unit having simplified structure |
| JPH084508B2 (ja) | 1987-09-16 | 1996-01-24 | 国立予防衛生研究所長 | 組み換えワクチニアウイルス |
| JP2511494B2 (ja) | 1988-05-12 | 1996-06-26 | 善治 松浦 | 日本脳炎ウイルス表面抗原蛋白質の製造法 |
| US6184024B1 (en) | 1988-07-14 | 2001-02-06 | The United States Of America As Represented By The Department Of Health And Human Services | Chimeric and/or growth-restricted flaviviruses |
| IL91304A0 (en) | 1988-08-20 | 1990-03-19 | Us Health | Recombinant vaccinia virus for prevention of disease caused by flavivirus |
| MY109299A (en) | 1990-08-15 | 1996-12-31 | Virogenetics Corp | Recombinant pox virus encoding flaviviral structural proteins |
| US5514375A (en) | 1990-08-15 | 1996-05-07 | Virogenetics Corporation | Flavivirus recombinant poxvirus vaccine |
| US5494671A (en) | 1990-08-27 | 1996-02-27 | The United States Of America As Represented By The Department Of Health And Human Services | C-terminally truncated dengue and Japanese encephalitis virus envelope proteins |
| DE69231570T2 (de) | 1991-09-19 | 2001-06-21 | Us Of America Represented By D | Chimäre und/oder wachstumgehemmte Flaviviren |
| JPH05276941A (ja) | 1992-02-28 | 1993-10-26 | Nippon Zeon Co Ltd | フラビウイルス科に属するウイルスの表面抗原タンパク質を含む非感染性の構造物粒子の製造方法 |
| WO1996037221A1 (en) | 1995-05-24 | 1996-11-28 | Hawaii Biotechnology Group, Inc. | Subunit vaccine against flavivirus infection |
| AU6093296A (en) | 1995-06-07 | 1996-12-30 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Infectious dengue 2 virus pdk-53 as quadravalent vaccine |
| HU228705B1 (en) | 1997-02-28 | 2013-05-28 | Univ St Louis | Chimeric flavivirus vaccines |
| ATE314476T1 (de) | 1997-10-08 | 2006-01-15 | Us Gov Health & Human Serv | Chimärer impfstoff gegen das zeckenenzephalitis virus |
| US7417136B1 (en) | 1998-06-04 | 2008-08-26 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention | Nucleic acid vaccines for prevention of flavivirus infection |
| EP3000477A1 (en) | 2000-02-16 | 2016-03-30 | The Government of The United States of America, as represented by the Secretary, Department of Health and Human Services, | Avirulent, immunogenic flavivirus chimeras |
| WO2002072036A2 (en) | 2001-03-12 | 2002-09-19 | Yale University | Compositions and methods comprising west nile virus polypeptides |
| US20040259224A1 (en) | 2002-05-31 | 2004-12-23 | Farshad Guirakhoo | Tetravalent Dengue vaccines |
| BRPI0613287A2 (pt) | 2005-06-17 | 2010-12-28 | Sanofi Pasteur | cepa do vìrus da dengue-2 vivo atenuada, composição imunogênica, composição de vacina, ácido nucléico isolado, poliproteìna isolada codificadas pela seq id n .1 ou fragmentos desta e fragmento da poliproteìna |
| US20080193477A1 (en) | 2005-08-10 | 2008-08-14 | Acambis Inc. | Vaccination Against Dengue Virus Infection |
| FR2903605A1 (fr) | 2006-07-12 | 2008-01-18 | Sanofi Pasteur Sa | Methode d'immunisation contre les quatres serotypes de la dengue |
| FR2906724B1 (fr) | 2006-10-04 | 2009-03-20 | Sanofi Pasteur Sa | Methode d'immunisation contre les 4 serotypes de la dengue. |
| FR2909286B1 (fr) | 2006-12-01 | 2012-06-08 | Sanofi Pasteur | Methode d'immunisation contre les 4 serotypes de la dengue |
| DK2178903T3 (da) | 2007-07-13 | 2012-06-18 | Florida Gulf Coast University | Optimeret denguevirus-adgangsinhiberede peptid (DN81) |
| SG157244A1 (en) | 2008-05-15 | 2009-12-29 | Mp Biomedicals Asia Pacific Pte Ltd | Point of care test for the detection of exposure or immunity to dengue virus |
| WO2010085358A2 (en) | 2009-01-23 | 2010-07-29 | The Board Of Regents Of The University Of Texas System | Flaviviruses expressing the prm, e, and ns1 proteins of other flaviviruses and uses thereof |
| NZ597000A (en) | 2009-06-01 | 2014-07-25 | Takeda Vaccines Inc | Compositions and methods for administration of vaccines against dengue virus |
| US8968996B2 (en) | 2009-06-01 | 2015-03-03 | Takeda Vaccines, Inc. | Compositions and methods for rapid immunization against dengue virus |
| BRPI0904020B8 (pt) | 2009-10-01 | 2021-05-25 | Fundacao Oswaldo Cruz | composição vacinal contra o vírus da dengue, e, kit |
| EP2353609A1 (en) | 2010-02-04 | 2011-08-10 | Sanofi Pasteur | Immunization compositions and methods |
| NZ630831A (en) | 2012-06-10 | 2019-02-22 | Takeda Vaccines Inc | Compositions and methods for administration of vaccines against dengue virus |
| KR20150036593A (ko) | 2012-07-24 | 2015-04-07 | 사노피 파스퇴르 | 뎅기열 바이러스 감염 예방용 백신 조성물 |
| MX381497B (es) | 2012-07-24 | 2025-03-12 | Sanofi Pasteur | Composiciones vacuna. |
| TW201920677A (zh) | 2012-11-08 | 2019-06-01 | 美商武田疫苗股份有限公司 | 登革熱病毒血清型４型之建構物的組成物、方法及用途 |
| JP2016504315A (ja) * | 2012-12-14 | 2016-02-12 | タケダ ワクチン, インコーポレイテッドTakeda Vaccines, Inc. | 三価デングウイルス製剤に関する組成物、投与方法および使用 |
| HRP20231581T1 (hr) | 2013-03-15 | 2024-03-15 | Takeda Vaccines, Inc. | Pripravci i postupci za kimerne konstrukte virusa denga groznice u cjepivima |
| TWI852899B (zh) | 2014-09-02 | 2024-08-21 | 法商賽諾菲巴斯德公司 | 疫苗組合物 |
| WO2017005654A1 (en) | 2015-07-03 | 2017-01-12 | Sanofi Pasteur | Concomitant dengue, diphtheria, tetanus, whooping cough (pertussis), polio, and haemophilus influenzae type b vaccination. |
| BR112017028212A2 (pt) | 2015-07-03 | 2018-09-11 | Sanofi Pasteur | vacinação concomitante contra dengue e febre amarela |
| US10004795B2 (en) | 2015-09-08 | 2018-06-26 | Fundacao Butantan | Process for preparing an attenuated tetravalent dengue vaccine |
| US11007261B2 (en) * | 2016-04-13 | 2021-05-18 | Takeda Vaccines, Inc. | Compositions and methods of vaccination against dengue virus in children and young adults |
| SG10201607778XA (en) | 2016-09-16 | 2018-04-27 | Chugai Pharmaceutical Co Ltd | Anti-Dengue Virus Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use |
| US11464815B2 (en) * | 2018-09-05 | 2022-10-11 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
| WO2020051334A1 (en) * | 2018-09-05 | 2020-03-12 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
-
2019
- 2019-09-05 WO PCT/US2019/049749 patent/WO2020051334A1/en not_active Ceased
- 2019-09-05 JP JP2021512482A patent/JP7579780B2/ja active Active
- 2019-09-05 AU AU2019335006A patent/AU2019335006B2/en active Active
- 2019-09-05 MX MX2021002586A patent/MX2021002586A/es unknown
- 2019-09-05 EP EP19769699.0A patent/EP3846849A1/en active Pending
- 2019-09-05 US US16/561,953 patent/US11590221B2/en active Active
- 2019-09-05 DK DK19195692.9T patent/DK3620174T3/da active
- 2019-09-05 CN CN201980070866.0A patent/CN112912106A/zh active Pending
- 2019-09-05 EP EP22151940.8A patent/EP4082568A1/en active Pending
- 2019-09-05 EP EP19195692.9A patent/EP3620174B1/en active Active
- 2019-09-05 US US17/274,016 patent/US20220226401A1/en active Pending
- 2019-09-05 SG SG11202102104SA patent/SG11202102104SA/en unknown
- 2019-09-05 IL IL298307A patent/IL298307A/en unknown
- 2019-09-05 KR KR1020217009759A patent/KR20210071979A/ko active Pending
- 2019-09-05 CA CA3111332A patent/CA3111332A1/en active Pending
- 2019-09-05 ES ES19195692T patent/ES2908304T3/es active Active
- 2019-09-05 PE PE2021000288A patent/PE20211545A1/es unknown
- 2019-09-05 BR BR112021003962-7A patent/BR112021003962A2/pt unknown
- 2019-09-05 IL IL281177A patent/IL281177B2/en unknown
-
2021
- 2021-03-05 PH PH12021550479A patent/PH12021550479A1/en unknown
- 2021-03-29 CO CONC2021/0003931A patent/CO2021003931A2/es unknown
- 2021-04-05 EC ECSENADI202123398A patent/ECSP21023398A/es unknown
-
2023
- 2023-01-04 US US18/149,742 patent/US20230355748A1/en active Pending
-
2024
- 2024-04-03 JP JP2024060499A patent/JP7791925B2/ja active Active
- 2024-09-26 AU AU2024220111A patent/AU2024220111B9/en active Active
-
2025
- 2025-07-07 AU AU2025205182A patent/AU2025205182B1/en active Active
- 2025-10-21 JP JP2025177428A patent/JP2026031938A/ja active Pending
- 2025-12-10 AU AU2025279696A patent/AU2025279696A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024105238A5 (https=) | ||
| Srivastava et al. | A purified inactivated Japanese encephalitis virus vaccine made in Vero cells | |
| AU2007327367B2 (en) | Immunization protocol against the 4 dengue serotypes | |
| JP2026031938A5 (https=) | ||
| US8784839B2 (en) | Attenuated live vaccines | |
| Murrell et al. | Review of dengue virus and the development of a vaccine | |
| Mota et al. | Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein | |
| JP5295956B2 (ja) | ４種のデング熱血清型に対する免疫付与の方法 | |
| JP2021536463A5 (https=) | ||
| JP2003523189A (ja) | 無毒性の免疫原性フラビウイルスキメラ | |
| Rohde et al. | A new recombinant Orf virus (ORFV, Parapoxvirus) protects rabbits against lethal infection with rabbit hemorrhagic disease virus (RHDV) | |
| WO2020051328A1 (en) | Assay for determining antibody response to dengue virus | |
| JPWO2020051334A5 (https=) | ||
| Oh et al. | A purified inactivated vaccine derived from Vero cell-adapted zika virus elicits protection in mice | |
| CN103757032B (zh) | 一种以流感病毒为载体的hcv嵌合疫苗及其制备方法 | |
| Wu et al. | Sub-fragments of the envelope gene are highly protective against the Japanese encephalitis virus lethal infection in DNA priming—protein boosting immunization strategies | |
| Boscardin | Dengue vaccines | |
| WO2020184730A1 (ja) | デングウイルスワクチン | |
| JP7232289B2 (ja) | デングウイルス弱毒株をバンク化した生ウイルス、及びそれらを抗原とするデングワクチン | |
| Koff | Problem hepatitis viruses: the mutants | |
| CN113227360A (zh) | 具有新型流感病毒来源的血凝素蛋白基因的DIs株来源的重组牛痘病毒 | |
| Akuta et al. | Effect of acute self-limited hepatitis C virus (HCV) superinfection on hepatitis B virus (HBV)-related cirrhosis. Virological features of HBV–HCV dual infection | |
| Gomez-Escobar et al. | One step closer to a pan-genotypic hepatitis C vaccine | |
| CN119562960A (zh) | 作为抗丙型肝炎病毒疫苗的vsv载体编码的hcv包膜蛋白e1/e2 | |
| JP2024503482A (ja) | 複製可能アデノウイルス４型ｓａｒｓ－ｃｏｖ－２ワクチンおよびそれらの使用 |